- Home
- MDGL vs VIPS Comparison
MDGL vs VIPS Comparison
Compare MDGL & VIPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- VIPS
- Stock Information
- Founded
- MDGL 2011
- VIPS 2008
- Country
- MDGL United States
- VIPS China
- Employees
- MDGL N/A
- VIPS N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- VIPS Catalog/Specialty Distribution
- Sector
- MDGL Health Care
- VIPS Consumer Discretionary
- Exchange
- MDGL Nasdaq
- VIPS Nasdaq
- Market Cap
- MDGL 9.6B
- VIPS 9.1B
- IPO Year
- MDGL N/A
- VIPS 2012
- Fundamental
- Price
- MDGL $423.00
- VIPS $17.83
- Analyst Decision
- MDGL Strong Buy
- VIPS Buy
- Analyst Count
- MDGL 12
- VIPS 5
- Target Price
- MDGL $521.09
- VIPS $18.33
- AVG Volume (30 Days)
- MDGL 277.8K
- VIPS 2.3M
- Earning Date
- MDGL 11-04-2025
- VIPS 11-18-2025
- Dividend Yield
- MDGL N/A
- VIPS 2.62%
- EPS Growth
- MDGL N/A
- VIPS N/A
- EPS
- MDGL N/A
- VIPS 1.86
- Revenue
- MDGL $515,547,000.00
- VIPS $14,793,082,721.00
- Revenue This Year
- MDGL $394.38
- VIPS $0.74
- Revenue Next Year
- MDGL $64.73
- VIPS $2.13
- P/E Ratio
- MDGL N/A
- VIPS $9.86
- Revenue Growth
- MDGL 3421.98
- VIPS N/A
- 52 Week Low
- MDGL $213.71
- VIPS $12.14
- 52 Week High
- MDGL $463.63
- VIPS $21.08
- Technical
- Relative Strength Index (RSI)
- MDGL 46.03
- VIPS 44.36
- Support Level
- MDGL $413.82
- VIPS $18.23
- Resistance Level
- MDGL $436.79
- VIPS $19.25
- Average True Range (ATR)
- MDGL 18.12
- VIPS 0.52
- MACD
- MDGL -2.63
- VIPS -0.16
- Stochastic Oscillator
- MDGL 48.76
- VIPS 6.04
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About VIPS Vipshop Holdings Limited
Vipshop is a leading Chinese online discount retailer offering branded products at attractive discounts ranging from 10%-90% off their original price through daily flash sales. It operates warehousing, retailing, product procurements, software development, and information technology support in-house while outsourcing to third-party logistics providers for distribution and shipments. Branded products on Vipshop's platform are sourced mostly through a consignment model with global brand partners . As of March 31, 2025, Eric Ya Shen, chairman and CEO, had 64.5% voting rights. Leading Chinese social media firm and strategic shareholder Tencent also holds an 12.5% interest.